Product review · Updated September 30, 2026
Revolution Clear Canvas review: the product code behind the comfort percentage
Keep the UK serum’s current declaration, an older product code and the four-week consumer responses distinct.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Revolution’s Clear Canvas clarifying serum pairs 5% niacinamide with 2% salicylic acid and prominently reports that consumers did not find it drying or irritating. The whole-product question begins before that percentage: which serum page and ingredient version does the account accompany? Two official records have similar descriptions but different product codes and a small declaration difference.
We read the UK-facing Clear Canvas record and the older-named Salicylic Acid & Niacinamide Serum page on September 30, 2026. The current review is anchored to code 1833264. The other page is useful for identifying the version boundary, not for assuming a bottle, price, stock status or formulation is interchangeable across the two codes.
In this article
Clear Canvas has its own product code
The chosen page names Revolution Skin Clear Canvas 5% Niacinamide & 2% Salicylic Acid Clarifying Serum and lists product code 1833264. The separate Revolution Skincare Salicylic Acid & Niacinamide Serum page lists code 1617857. Similar wording does not erase those identifiers or establish that every item carrying the older name matches this review. Clear Canvas; older-named record.
Both records are UK-facing offers with pound-denominated displays. Their visible availability markers were page content at the review date, not an order or supply verification. This article does not transfer the older page’s offer to the chosen code, infer a US drug classification or claim the date on which any commercial or formula change occurred.
Two percentages describe two different ingredients
The manufacturer assigns 5% to niacinamide and 2% to salicylic acid. Its description combines pore, blemish, redness and texture claims within one clarifying-serum narrative. Those declarations identify the advertised blend; adding the numbers together would not provide a meaningful salicylic strength or a measured comparison with a different formula. Blend discussion.
The full list matters beside that headline pair. It names glycerin, propanediol, panthenol and additional ingredients rather than documenting a two-component mixture. The combination-formula guide provides context for reading several advertised components without assuming the finished product inherits a particular comfort result from each one in isolation. Complete declaration.
The two full lists deserve separate treatment
The declaration for code 1833264 places sodium hydroxide before disodium EDTA. The code 1617857 record reverses those two entries. This is a documented difference in the returned lists. It is not enough to establish a concentration change, an identical batch formula or the manufacturing reason behind the different ordering. Current list; other-code list.
FDA’s cosmetic-label guide explains that ordering has exceptions, including ingredients at 1% or less. That helps limit what can be inferred from a list, without determining UK compliance or classifying this product as a US medicine. The Minimalist review is another product-documentation destination, rather than evidence that the two brands have equivalent blends. Ordering context.
The 98% figure comes from a consumer account
Revolution states that 98% said the product did not irritate or dry their skin. The footnote identifies testing on 52 consumers over four weeks. That denominator and period belong beside the response; removing them would make a bounded group report look like an assurance about everyone who might encounter the serum. Reported results.
The retained page does not provide the complete protocol, recruitment criteria or comparison conditions. The wording is a consumer report attributed to the manufacturer, not an independently reviewed head-to-head trial. It does not tell us what a person with a different skin condition, a different product version or a different set of existing products will experience.
Hydration and clearer appearance are separate responses
The same panel reports 92% agreement about immediate hydration, 92% about less-red and clearer-looking skin after four weeks, and 92% about more-even texture after four weeks. It also reports 96% willingness to recommend the product. These are distinct statements, not one clinical outcome or a measure of how this formula compares with another brand. Response panel.
A recommendation response may be useful to understanding the seller’s account, but it does not disclose irritation severity, acne lesion counts or the missing full methods. The Versed review is a separate reading option for another serum. Its inclusion here does not create a pooled study, matched cohort or clinical ranking between the products.
Free-from wording cannot settle individual tolerance
Revolution calls the serum fragrance-free, alcohol-free, dermatologically tested and non-comedogenic. Those are the brand’s stated attributes. The no-irritation consumer response is a separate kind of evidence; neither the category labels nor that response establishes an individualized assessment or eliminates the possibility of discomfort outside the reported group. Product positioning.
AAD identifies salicylic acid as an acne-treatment ingredient that may dry or irritate skin. That general context does not contradict every favorable consumer report and is not a study of this serum. The mature dry-skin guide considers the comfort question without supplying a personal routine or treating the manufacturer’s audience wording as clinical clearance. AAD explanation.
The code and study boundary stay with the comparison
The current Clear Canvas page supplies a named serum, two declared ingredient quantities, a complete list and a consumer summary with a stated denominator and period. The other code supplies a useful version contrast. Those strengths leave the underlying report, individual tolerability and equivalence of unseen packages unresolved. Current record; separate code.
The product comparison offers broader reading about format and evidence. For this serum, the careful comparison preserves the exact code and consumer frame rather than turning 98% into a universal safety claim. It does not transfer an older offer, guess percentages from list order or declare a winner on the basis of marketing responses.
Sources behind this reading
- Revolution Skin Clear Canvas 5% Niacinamide & 2% Salicylic Serum: code 1833264 ↗Official manufacturer public product/brand record; source-specific scope · Checked September 30, 2026
- Revolution Skincare Salicylic Acid & Niacinamide Serum: code 1617857 record ↗Official manufacturer public product/brand record; source-specific scope · Checked September 30, 2026
- FDA Cosmetics Labeling Guide: ingredient-declaration context ↗Regulator selected labeling passages; not a product compliance audit · Checked September 30, 2026
- American Academy of Dermatology: moisturizer and acne treatment ↗Medical society patient guidance · Checked September 30, 2026